| |
| |
|
Dr. Miller joined Ulthera in June of 2006. He has spent over 25 years in the medical device and pharmaceutical/biotech industries, resulting in product approvals across a number of therapeutic areas generating over $800 million in annual revenues.
Dr. Miller has extensive experience in leading cross-functional teams on manufacturing processes, quality assurance and regulatory submission preparation for start-ups, mid-sized and Fortune 500 firms. These include Abbott Laboratories, Dow Chemical, Dey Labs, DSI International and ImaRx Therapeutics. Dr. Miller’s expertise in product development, clinical trial planning and management, and regulatory strategy is invaluable as Ulthera progresses from its infancy as a start-up to the maturity of a formidable leader in the aesthetics market. He graduated from Vanderbilt University with a Ph.D. in pharmacology. |
|
|
